share_log

开立医疗(300633.SZ)：预期未来海外业务将保持稳定增长趋势

Established Healthcare (300633.SZ): Overseas business is expected to maintain a steady growth trend in the future

Gelonghui Finance ·  Mar 12 03:33

On March 12, Gelonghui Healthcare (300633.SZ) was recently surveyed by a specific target on “the development status and prospects of the company's overseas business?” The company replied that as the earliest domestic medical equipment manufacturer to start overseas business, the company's medical equipment exports have been among the highest in the industry for many years. The company has been adhering to the “domestic+international” market development for a long time. In recent years, the company's overseas business revenue has continued to grow. It has broken through the 100 million US dollar mark in 2022 and continued to grow in 2023. The overseas market is extremely broad. Through years of hard work, the company has established a marketing network covering more than 170 countries or regions around the world, and has established overseas marketing subsidiaries in Germany, India, the Netherlands, the United States, etc., to recruit local personnel to work, strengthen cooperation between the company and overseas medical terminals, and increase the influence of the company's brand overseas. The company expects the overseas business to maintain a steady growth trend in the future.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment